[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-253469-105":53,"doc-detail-253469-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","competitive-intelligence-in-an-agile-world-adapting-intelligence-functions-to-an-increasingly-complex-pharma-landscape","COMPETITIVE INTELLIGENCE IN AN AGILE WORLD - Adapting intelligence functions to an increasingly complex pharma landscape","","Competitive Intelligence in an Agile World explores how agile working can reshape intelligence functions for pharma teams and managers facing a complex, dynamic environment. It contrasts waterfall clinical-trial decision structures—anchored in tightly regulated, multi-phase protocols and large volumes of reporting—with adaptive designs that can adjust as new information emerges. The piece defines agile as a methodology for enabling teams to succeed amid uncertainty, outlining key concepts such as scrum, cross-functional collaboration, short work cycles, and leadership roles that evolve with sprint tasks.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/competitive-intelligence-in-an-agile-world-adapting-intelligence-functions-to-an-increasingly-complex-pharma-landscape/253469/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/competitive-intelligence-in-an-agile-world-adapting-intelligence-functions-to-an-increasingly-complex-pharma-landscape/253469.png","ImageObject",442,249,{"name":88,"@type":89},"Elsa","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-28","2026-09-13",true,{"@type":98,"interactionType":99,"userInteractionCount":8},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What problem does the document say agile working helps pharma CI teams solve?","Question",{"text":108,"@type":109},"It helps teams deal with uncertainty and complexity in fast-paced environments, improving success in dynamic conditions rather than relying on rigid early decisions.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"How does the document connect FDA adaptive-design guidance to agile thinking?",{"text":113,"@type":109},"It cites the idea that adaptive trials can adjust based on information not available at trial start, implying alignment with agile principles.",{"name":115,"@type":106,"acceptedAnswer":116},"What are the core agile concepts introduced in the document?",{"text":117,"@type":109},"It emphasizes scrum, cross-functional teams, and short-term work cycles (sprints) where discrete elements are delivered in manageable increments, with leadership responsibilities shifting by sprint needs.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},253469,1791716922,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":8,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":135,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":76},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","COMPETITIVE INTELLIGENCE IN AN AGILE WORLD  \nAdapting intelligence functions to an increasingly complex pharma landscape  \n+44 (0)207 337 6900 [info@deallus.com](info@deallus.com)[ ](info@deallus.com)[deallus.com](deallus.com)  \nCOMPETITIVE INTELLIGENCE IN AN AGILE WORLD  \nThis thought piece explores the concept of agile working for the pharma world, delving into the opportunities and challenges that arise for CI teams and managers as working environments adapt to find success in a more dynamic, uncertain, and fast-paced environment.  \nIf agile is the answer, what is the question?  \nAt the heart of pharma stands the monolith that is the clinical trial protocol: three phases; strict regulations governing every aspect of each; enormous quantities of clinical study report data to be captured and translated into coherence. This is the template that pharmaceutical companies have incorporated into every aspect of their decision-making process. Upon these three cascading phased tiers are all pharma workflow decisions made. This structure is immutable, and pharma companies monkey with it at their peril.  \nExcept... recent guidance from the FDA practically begs them to monkey with it. Consider the September 2018 guidance for industry, Adaptive Designs for Clinical Trials of Drugs and Biologics:  \n“Adaptive designs can provide a variety of advantages over non-adaptive designs. These advantages arise from the fundamental property of clinical trials with an adaptive design: they allow the trial to adjust to information that was not available when the trial began.”1  \nTo anyone familiar with the plethora of modern workflow and productivity systems, that last sentence-allowing the trial to adjust to information not available at the beginning-can only mean one thing:  \nSomebody at the FDA knows-and caresabout agile.  \nSo, what is agile working?  \nAgile refers to a working methodology focused on better enabling teams and functions to deal with, and succeed in, uncertain environments.²  \nAt first impression, agile may seem chaotic, anarchic, and almost perversely committed to a lack of managerial accountability. When seen from inside, however, the creation of a uniquely skilled, hardworking and disciplined team is an ideal solution to the problem imposed by large, slow-moving, inflexible projects composed of many smaller moving pieces.  \n1 [https://www. mckinsey.com/~/media/McKinsey/Industries/](https://www. mckinsey.com/~/media/McKinsey/Industries/)[ ](https://www. mckinsey.com/~/media/McKinsey/Industries/)Pharmaceuticals%20and%20Medical%20Products/Our%20 Insights/R%20and%20D%20in%20the%20age%20of%20 agile/R-and-D-in-the-age-of-agile. ashx  \n2 [https://techbeacon.com/app-dev-testing/agility-beyond](https://techbeacon.com/app-dev-testing/agility-beyond)history-legacy-agile-development  \n3 [http://www. scrum-breakfast.com/2013/01/how-do-you-do](http://www. scrum-breakfast.com/2013/01/how-do-you-do)scrum-in-regulated.html  \n4 [https://www. pmis-consulting.com/agile-versus-waterfall/](https://www. pmis-consulting.com/agile-versus-waterfall/)  \nAgile working: key concepts  \nWaterfall working systems Agile working systems  \nTraditional workflows in which all of the most important decisions must be made right at the beginning of a project, when the least is known. Each preceding tier must be completed before action on the next can begin.  \nCommon negatives: frustration, personnel overtime, unplanned expenses.  \nPhase 1  \nAdaptable workflows utilizing fit-toneed teams and many shorter-term work cycles, some of which can take place in tandem of one another.  \nThe focus is on increased stakeholder touchpoints that ensures the end product meets current needs.  \nSprint 1 Sprint 2 Sprint 3  \nTo counter the waterfall style of working, agile introduces two concepts:  \nThe scrum  \nThe cross-functional team working together to achieve a goal, comprised of individuals that are necessary to produce a final, functional deliverable  \nA short-term work cycle durin","cbCaioYZsTjBWjZc","https://ap.wps.com/l/cbCaioYZsTjBWjZc","pdf",539517,8,"English","# Agile working for the pharma world\n## Agile vs. waterfall approaches\n## Key concepts: scrum and cross-functional teams\n## Evidence of agile adoption in industry","[{\"question\":\"What problem does the document say agile working helps pharma CI teams solve?\",\"answer\":\"It helps teams deal with uncertainty and complexity in fast-paced environments, improving success in dynamic conditions rather than relying on rigid early decisions.\"},{\"question\":\"How does the document connect FDA adaptive-design guidance to agile thinking?\",\"answer\":\"It cites the idea that adaptive trials can adjust based on information not available at trial start, implying alignment with agile principles.\"},{\"question\":\"What are the core agile concepts introduced in the document?\",\"answer\":\"It emphasizes scrum, cross-functional teams, and short-term work cycles (sprints) where discrete elements are delivered in manageable increments, with leadership responsibilities shifting by sprint needs.\"}]","COMPETITIVE INTELLIGENCE IN AN AGILE WORLD - Adapting intelligence functions to an increasingly complex pharma landscape | PDF",1789266190]